Cargando…

Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD

PURPOSE: Cardiovascular disease (CVD) is the first cause of death in patients with non-alcoholic fatty liver disease (NAFLD) and risk stratification is recommended by current guidelines. The aim of this study is to assess the prevalence of peripheral arterial disease (PAD) in patients with NAFLD and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciardullo, S., Bianconi, E., Cannistraci, R., Parmeggiani, P., Marone, E. M., Perseghin, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270293/ https://www.ncbi.nlm.nih.gov/pubmed/35364761 http://dx.doi.org/10.1007/s40618-022-01792-9

Ejemplares similares

Serum neurofilament light chain levels are associated with all-cause mortality in the general US population
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications
por: Ciardullo, Stefano, et al.
Publicado: (2020)

Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis
por: Ciardullo, Stefano, et al.
Publicado: (2022)

NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy
por: Ciardullo, S., et al.
Publicado: (2020)

Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Mitochondrial DNA copy number is associated with all‐cause mortality and cardiovascular events in patients with peripheral arterial disease
por: Koller, A., et al.
Publicado: (2020)

Sites of Peripheral Artery Occlusive Disease as a Predictor for All-Cause and Cardiovascular Mortality in Chronic Hemodialysis
por: Tsai, Ming-Hsien, et al.
Publicado: (2015)

Association of peripheral arterial disease with all-cause and cardiovascular mortality in hemodialysis patients: a meta-analysis
por: Yang, Yi, et al.
Publicado: (2016)

Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank
por: Ma, Wen, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Soluble α-Klotho levels, glycemic control and renal function in US adults with type 2 diabetes
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Association of Lower Extremity Performance With Cardiovascular and All‐Cause Mortality in Patients With Peripheral Artery Disease: A Systematic Review and Meta‐Analysis
por: Morris, Dylan R., et al.
Publicado: (2014)

Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD
por: Linge, Jennifer, et al.
Publicado: (2022)

THU642 Progression To Cirrhosis And All-cause Mortality Are Increased In Postmenopausal Women With NAFLD
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2023)

Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Lack of awareness of liver organ damage in patients with type 2 diabetes
por: Ciardullo, Stefano, et al.
Publicado: (2021)

NAFLD and cardiovascular disease
por: Martins, Elisabete, et al.
Publicado: (2018)

Legume Consumption and All-Cause and Cardiovascular Disease Mortality
por: Li, Hua, et al.
Publicado: (2017)

Long-Term Outcomes Associated with NAFLD, ASCVD, and All-Cause Mortality of Patients with Metabolic Syndrome
por: Jitrukthai, Suchanart, et al.
Publicado: (2022)

Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
por: Margonato, Davide, et al.
Publicado: (2020)

NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III
por: Huang, Qi, et al.
Publicado: (2021)

Cholesterol Efflux Capacity Associates with the Ankle-Brachial Index but Not All-Cause Mortality in Patients with Peripheral Artery Disease
por: Clemens, Robert K., et al.
Publicado: (2021)

Body adiposity index and all-cause and cardiovascular disease mortality in men
por: Moliner-Urdiales, Diego, et al.
Publicado: (2013)

The Adiponectin Paradox for All-Cause and Cardiovascular Mortality
por: Menzaghi, Claudia, et al.
Publicado: (2018)

Alcohol Consumption and Risk of All-Cause and Cardiovascular Disease Mortality in Men
por: Howie, Erin K., et al.
Publicado: (2011)

Phenotypes of non-alcoholic fatty liver disease (NAFLD) and all-cause mortality: unsupervised machine learning analysis of NHANES III
por: Carrillo-Larco, Rodrigo M, et al.
Publicado: (2022)

Race/Ethnicity and the Prognostic Implications of Coronary Artery Calcium for All‐Cause and Cardiovascular Disease Mortality: The Coronary Artery Calcium Consortium
por: Orimoloye, Olusola A., et al.
Publicado: (2018)

Impact of diabesity phenotype on cardiovascular diseases, major cardiovascular events and all-cause mortality
por: Mehrabani-Zeinabad, Kamran, et al.
Publicado: (2023)

Diabetes modifies the association of prehypertension with cardiovascular disease and all‐cause mortality
por: Ren, Yanlong, et al.
Publicado: (2021)

Dairy intake in relation to cardiovascular disease mortality and all-cause mortality: the Hoorn Study
por: van Aerde, Marieke A., et al.
Publicado: (2012)

Seropositivity to Cytomegalovirus, Inflammation, All-Cause and Cardiovascular Disease-Related Mortality in the United States
por: Simanek, Amanda M., et al.
Publicado: (2011)

Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Association between egg consumption and cardiovascular disease events, diabetes and all-cause mortality
por: Guo, Jing, et al.
Publicado: (2017)

Cardiorespiratory fitness estimations and their ability to predict all-cause mortality in patients with cardiovascular disease
por: Peterman, James E., et al.
Publicado: (2022)

Association of vitamin B1 with cardiovascular diseases, all-cause and cardiovascular mortality in US adults
por: Wen, He, et al.
Publicado: (2023)

Serum Levels of Monocyte Chemoattractant Protein-1 and All-Cause and Cardiovascular Mortality among Patients with Coronary Artery Disease
por: Ding, Ding, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oui67dmnpju2ejnm8f3qcv14kn